Sean P. Nolan - Net Worth and Insider Trading

Sean P. Nolan Net Worth

The estimated net worth of Sean P. Nolan is at least $4 Million dollars as of 2024-05-12. Sean P. Nolan is the CEO of Taysha Gene Therapies Inc and owns about 1,536,715 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $4 Million. Sean P. Nolan is also the President & CEO of AveXis Inc and owns about 0 shares of AveXis Inc (AVXS) stock worth over $0. Details can be seen in Sean P. Nolan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sean P. Nolan has not made any transactions after 2023-08-16 and currently still holds the listed stock(s).

Transaction Summary of Sean P. Nolan

To

Sean P. Nolan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean P. Nolan owns 5 companies in total, including Taysha Gene Therapies Inc (TSHA) , Ventas Inc (VTR) , and Neoleukin Therapeutics Inc (NLTX) among others .

Click here to see the complete history of Sean P. Nolan’s form 4 insider trades.

Insider Ownership Summary of Sean P. Nolan

Ticker Comapny Transaction Date Type of Owner
TSHA Taysha Gene Therapies Inc 2023-08-16 director
VTR Ventas Inc 2019-07-26 director
NLTX Neoleukin Therapeutics Inc 2019-10-10 director
2018-05-15 director & President & CEO
2021-09-24 director

Sean P. Nolan Latest Holdings Summary

Sean P. Nolan currently owns a total of 2 stocks. Among these stocks, Sean P. Nolan owns 1,536,715 shares of Taysha Gene Therapies Inc (TSHA) as of August 16, 2023, with a value of $4 Million and a weighting of 100%. Sean P. Nolan also owns 0 shares of AveXis Inc (AVXS) as of March 7, 2018, with a value of $0 and a weighting of 0%.

Latest Holdings of Sean P. Nolan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSHA Taysha Gene Therapies Inc 2023-08-16 1,536,715 2.34 3,595,913
AVXS AveXis Inc 2018-03-07 0 217.83 0

Holding Weightings of Sean P. Nolan


Sean P. Nolan Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean P. Nolan has made a total of 2 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Taysha Gene Therapies Inc is the acquisition of 444,444 shares on August 16, 2023, which cost Sean P. Nolan around $400,000.

According to the SEC Form 4 filings, Sean P. Nolan has made a total of 0 transactions in AveXis Inc (AVXS) over the past 5 years. The most-recent trade in AveXis Inc is the sale of 10,000 shares on March 7, 2018, which brought Sean P. Nolan around $1 Million.

Insider Trading History of Sean P. Nolan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean P. Nolan Trading Performance

GuruFocus tracks the stock performance after each of Sean P. Nolan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean P. Nolan is -20.25%. GuruFocus also compares Sean P. Nolan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean P. Nolan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sean P. Nolan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sean P. Nolan

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 44.7
Relative Return to S&P 500(%) 44.09

Sean P. Nolan Ownership Network

Ownership Network List of Sean P. Nolan

No Data

Ownership Network Relation of Sean P. Nolan


Sean P. Nolan Owned Company Details

What does Taysha Gene Therapies Inc do?

Who are the key executives at Taysha Gene Therapies Inc?

Sean P. Nolan is the director of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Session R.a. Ii .

Taysha Gene Therapies Inc (TSHA) Insider Trades Summary

Over the past 18 months, Sean P. Nolan made 1 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net purchase of 444,444. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net sale of 549,095 shares made by Session R.a. Ii , a net purchase of 16,566,667 shares made by Paul B Manning , and a net purchase of 777,778 shares made by Stalfort John A Iii .

In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 17,905,000 shares were bought by its insiders, resulting in a net purchase of 17,322,905 shares.

Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Taysha Gene Therapies Inc Insider Transactions

No Available Data

Sean P. Nolan Mailing Address

Above is the net worth, insider trading, and ownership report for Sean P. Nolan. You might contact Sean P. Nolan via mailing address: C/o Intermune, Inc., 3280 Bayshore Blvd., Brisbane Ca 94005.

Discussions on Sean P. Nolan

No discussions yet.